2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits fibroblast growth factor 10-induced prostatic bud formation in mouse urogenital sinus

Toxicological Sciences

Volumn 113, Issue 1, 2009, Pages 198-206

  Vezina, Chad M ^a,b   Hardin, Heather A ^b   Moore, Robert W ^b   Allgeier, Sarah H ^b   Peterson, Richard E ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Development; Fibroblast growth factor 10; Mouse; Prostate; TCDD; Urogenital sinus

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1B1; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

AGENESIS; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM BASAL CELL; FETUS; FETUS DEVELOPMENT; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; ORGAN CULTURE; ORGANOGENESIS; PRENATAL EXPOSURE; PROSTATE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TERATOGENESIS; UROGENITAL SINUS;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELL PROLIFERATION; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLAST GROWTH FACTOR 10; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GESTATIONAL AGE; MALE; MICE; MICE, INBRED C57BL; ORGAN CULTURE TECHNIQUES; PREGNANCY; PROSTATE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RNA, MESSENGER; SIGNAL TRANSDUCTION; TERATOGENS; TETRACHLORODIBENZODIOXIN;

MUS;

EID: 75249087916     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp226     Document Type: Article

References (42)

1. Abbott, B.D., Lin, T.M., Rasmussen, N.T., Albrecht, R.M., Schmid, J.E., and Peterson, R.E. (2003). Lack of expression of EGF and TGF-alpha in the fetal mouse alters formation of prostatic epithelial buds and influences the response to TCDD. Toxicol. Sci. 76, 427-436.
2. Allgeier, S.H., Lin, T.M., Vezina, C.M., Moore, R.W., Fritz, W.A., Chiu, S.Y., Zhang, C., and Peterson, R.E. (2008). WNT5A selectively inhibits mouse ventral prostate development. Dev. Biol. 324, 10-17.
3. Bates, C.M. (2007). Role of fibroblast growth factor receptor signaling in kidney development. Pediatr. Nephrol. 22, 343-349.
4. Bellusci, S., Grindley, J., Emoto, H., Itoh, N., and Hogan, B.L. (1997). Fibroblast growth factor 10 (FGF10) and branching morphogenesis in the embryonic mouse lung. Development 124, 4867-4878.
5. Cook, C., Vezina, C.M., Allgeier, S.H., Shaw, A., Yu, M., Peterson, R.E., and Bushman, W. (2007). Noggin is required for normal lobe patterning and ductal budding in the mouse prostate. Dev. Biol. 312, 217-230.
6. Cunha, G.R., and Chung, L.W. (1981). Stromal-epithelial interactions-I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice. J. Steroid Biochem. 14, 1317-1324.
7. Cunha, G.R., and Lung, B. (1978). The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J. Exp. Zool. 205, 181-193.
8. Donjacour, A.A., Thomson, A.A., and Cunha, G.R. (2003). FGF-10 plays an essential role in the growth of the fetal prostate. Dev. Biol. 261, 39-54.
9. Fritz, W.A., Lin, T.M., Moore, R.W., Cooke, P.S., and Peterson, R.E. (2005). In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on the prostate and its response to castration in senescent C57BL/6J mice. Toxicol. Sci. 86, 387-395.
10. Gao, N., Ishii, K., Mirosevich, J., Kuwajima, S., Oppenheimer, S.R., Roberts, R.L., Jiang, M., Yu, X., Shappell, S.B., Caprioli, R.M., et al. (2005). Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 132, 3431-3443.
11. Hagan, M., Yacoub, A., and Dent, P. (2004). Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma. Clin. Cancer Res. 10, 5724-5731.
12. Howard, B., and Ashworth, A. (2006). Signalling pathways implicated in early mammary gland morphogenesis and breast cancer. PLoS Genet. 2, e112.
13. Huang, L., Pu, Y., Alam, S., Birch, L., and Prins, G.S. (2005). The role of Fgf10 signaling in branching morphogenesis and gene expression of the rat prostate gland: lobe-specific suppression by neonatal estrogens. Dev. Biol. 278, 396-414.
14. Isaac, A., Cohn, M.J., Ashby, P., Ataliotis, P., Spicer, D.B., Cooke, J., and Tickle, C. (2000). FGF and genes encoding transcription factors in early limb specification. Mech. Dev. 93, 41-48.
15. Ko, K., Moore, R.W., and Peterson, R.E. (2004a). Aryl hydrocarbon receptors in urogenital sinus mesenchyme mediate the inhibition of prostatic epithelial bud formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 196, 149-155.
16. Ko, K., Theobald, H.M., Moore, R.W., and Peterson, R.E. (2004b). Evidence that inhibited prostatic epithelial bud formation in 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed C57BL/6J fetal mice is not due to interruption of androgen signaling in the urogenital sinus. Toxicol. Sci. 79, 360-369.
17. Ko, K., Theobald, H.M., and Peterson, R.E. (2002). In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the C57BL/6J mouse prostate: lobe-specific effects on branching morphogenesis. Toxicol. Sci. 70, 227-237.
18. Kuslak, S.L., and Marker, P.C. (2007). Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud induction. Differentiation 75, 638-651.
19. Lin, T.-M., Fritz, W.A., Safe, S., and Peterson, R.E. (2009). TCDD and the selective aryl hydrocarbon receptor (AhR) modulators indole-3-carbinol (I3C) and 3, 3′-diindolylmethane (DIM) regulate prostate tumorigenesis in TRAMP mice. Toxicol. Sci. 108, 626.
20. Lin, T.M., Rasmussen, N.T., Moore, R.W., Albrecht, R.M., and Peterson, R.E. (2003). Region-specific inhibition of prostatic epithelial bud formation in the urogenital sinus of C57BL/6 mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 76, 171-181.
21. Lin, Y., Liu, G., Zhang, Y., Hu, Y.P., Yu, K., Lin, C., McKeehan, K., Xuan, J.W., Ornitz, D.M., Shen, M.M., et al. (2007). Fibroblast growth factor receptor 2 tyrosine kinase is required for prostatic morphogenesis and the acquisition of strict androgen dependency for adult tissue homeostasis. Development 134, 723-734.
22. McKay, M.M., and Morrison, D.K. (2007). Integrating signals from RTKs to ERK/MAPK. Oncogene 26, 3113-3121.
23. Meinhardt, H. (2008). Models of biological pattern formation: from elementary steps to the organization of embryonic axes. Curr. Top. Dev. Biol. 81, 1-63.
24. Memarzadeh, S., Xin, L., Mulholland, D.J., Mansukhani, A., Wu, H., Teitell, M.A., and Witte, O.N. (2007). Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor. Cancer Cell 12, 572-585.
25. Miki, T., Bottaro, D.P., Fleming, T.P., Smith, C.L., Burgess, W.H., Chan, A.M., and Aaronson, S.A. (1992). Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc. Natl. Acad. Sci. U.S.A. 89, 246-250.
26. Min, H., Danilenko, D.M., Scully, S.A., Bolon, B., Ring, B.D., Tarpley, J.E., DeRose, M., and Simonet, W.S. (1998). Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12, 3156-3161.
27. Mirosevich, J., Gao, N., and Matusik, R.J.(2005).Expression of Foxa transcription factors in the developing and adult murine prostate. Prostate 62, 339-352.
28. Nie, X., Luukko, K., and Kettunen, P. (2006). FGF signalling in craniofacial development and developmental disorders. Oral Dis. 12, 102-111.
29. Nyeng, P., Norgaard, G.A., Kobberup, S., and Jensen, J. (2007). FGF10 signaling controls stomach morphogenesis. Dev. Biol. 303, 295-310.
30. Paine-Saunders, S., Viviano, B.L., Economides, A.N., and Saunders, S. (2002). Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J. Biol. Chem. 277, 2089-2096.
31. Pu, Y., Huang, L., Birch, L., and Prins, G.S. (2007). Androgen regulation of prostate morphoregulatory gene expression: Fgf10-dependent and -independent pathways. Endocrinology 148, 1697-1706.
32. Putz, T., Culig, Z., Eder, I.E., Nessler-Menardi, C., Bartsch, G., Grunicke, H., Uberall, F., and Klocker, H. (1999). Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Cancer Res. 59, 227-233.
33. Saito, M., and Mizuno, T. (1995). Le facteur de croissance de l'epiderme (EGF) peut induire des bourgeons prostatiques en l'absence d'androgenes. [Epidermal growth factor (EGF) can induce prostatic buds in the absence of androgens]. C.R. Seances Soc. Biol. Fil. 189, 637-641.
34. Sekine, K., Ohuchi, H., Fujiwara, M., Yamasaki, M., Yoshizawa, T., Sato, T., Yagishita, N., Matsui, D., Koga, Y., Itoh, N., et al. (1999). Fgf10 is essential for limb and lung formation. Nat. Genet. 21, 138-141.
35. Sugimura, Y., Cunha, G.R., and Donjacour, A.A. (1986). Morphogenesis of ductal networks in the mouse prostate. Biol. Reprod. 34, 961-971.
36. Thomsen, M.K., Butler, C.M., Shen, M.M., and Swain, A. (2008). Sox9 is required for prostate development. Dev. Biol. 316, 302-311.
37. Thomson, A.A., and Cunha, G.R. (1999). Prostatic growth and development are regulated by FGF10. Development 126, 3693-3701.
38. Timme, T.L., Truong, L.D., Merz, V.W., Krebs, T., Kadmon, D., Flanders, K.C., Park, S.H., and Thompson, T.C. (1994). Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. Endocrinology 134, 1039-1045.
39. Timms, B.G., Lee, C.W., Aumuller, G., and Seitz, J. (1995). Instructive induction of prostate growth and differentiation by a defined urogenital sinus mesenchyme. Microsc. Res. Tech. 30, 319-332.
40. Timms, B.G., Mohs, T.J., and Didio, L.J. (1994). Ductal budding and branching patterns in the developing prostate. J. Urol. 151, 1427-1432.
41. Vezina, C.M., Allgeier, S.H., Fritz, W.A., Moore, R.W., Strerath, M., Bushman, W., and Peterson, R.E. (2008a). Retinoic acid induces prostatic bud formation. Dev. Dyn. 237, 1321-1333.
42. Vezina, C.M., Allgeier, S.H., Moore, R.W., Lin, T.M., Bemis, J.C., Hardin, H.A., Gasiewicz, T.A., and Peterson, R.E. (2008b). Dioxin causes ventral prostate agenesis by disrupting dorsoventral patterning in developing mouse prostate. Toxicol. Sci. 106, 488-496.